Hydrocortisone Workflows for Translational Assays
2026-09-07
Hydrocortisone provides a controlled glucocorticoid stimulus for receptor, inflammation, barrier, and stress-response experiments. This workflow connects that established use with the IGF2BP3–FZD1/7 findings in triple-negative breast cancer while clearly separating validated applications from hypothesis-generating assay extensions.
Cyclosporin: Mechanism and Research Use
2026-09-05
Cyclosporin A is a cyclophilin-dependent calcineurin inhibitor that suppresses NFAT signaling and cytokine production. This evidence-focused guide defines its molecular mechanism, mitochondrial applications, benchmark concentrations, research parameters, and key limitations.
Thymoquinone in Doxorubicin Cardiotoxicity
2026-09-05
A 2025 study reports that thymoquinone protected mouse hearts from doxorubicin-associated injury while improving antioxidant defenses, preserving mitochondria, and reducing ferroptosis-related changes. The findings identify Nrf2/HO-1 signaling as a plausible mechanism, but remain an early preclinical basis for further cardiotoxicity and translational studies.
SN-38 Disrupts FUBP1–FUSE DNA Binding
2026-09-04
The reference study identified camptothecin and SN-38 as inhibitors of the FUBP1–FUSE interaction, adding a transcriptional regulatory mechanism to their established topoisomerase I activity. Its screening, biochemical, and hepatocellular carcinoma cell experiments suggest that FUBP1 interference may contribute to the antitumor effects of SN-38, while also defining important limits for translating this finding to other cancer models.
Anlotinib Hydrochloride: From Target to Phenotype
2026-09-04
Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor whose value in cancer research depends on connecting receptor inhibition with ERK suppression and angiogenic phenotypes. This evidence-to-assay framework integrates endothelial models, pharmacokinetics, and a rare-tumor case report to improve experimental interpretation.
EZ Cap™ Cy5 EGFP mRNA: Dual-Readout Delivery
2026-09-03
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables simultaneous measurement of mRNA uptake and EGFP expression. This article explains how to use its dual signal architecture to diagnose targeting, intracellular trafficking, endosomal escape, and translation in advanced delivery studies.
CPSIT_0844 Activates TLR2/4 Inflammation
2026-09-03
The reference study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a proinflammatory factor that induces IL-6 and IL-8 in human monocytes. Genetic interference with TLR2, TLR4, and MyD88, together with downstream pathway analysis, supports a TLR2/TLR4–MyD88 axis connected to JNK, p38, and NF-κB signaling.
Hydrazide VEGFR-2 Inhibitors: SA7 and Sorafenib
2026-09-02
A 2026 ChemistrySelect study designed 53 hydrazide-based derivatives as VEGFR-2-directed antiangiogenic compounds and identified SA7 as a lead with cytotoxic, kinase-inhibitory, and in vivo antitumor activity. In the reported assay, SA7 inhibited VEGFR-2 at an IC50 of 2.206 μM, closely matching Sorafenib at 2.218 μM, while also suppressing endothelial network formation and HCT116 xenograft growth.
Y-27632 Dihydrochloride in ISC Aging
2026-09-02
Y-27632 dihydrochloride is a selective ROCK inhibitor for separating cytoskeletal, survival, and differentiation effects in intestinal stem cell models. This article connects ROCK pathway control with new findings on peroxisomal dysfunction and aging-associated stem cell mis-differentiation.
CBD Mechanisms in Orofacial Inflammatory Pain
2026-09-01
A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce inflammatory pain while also improving pain-related affective and cognitive abnormalities in mice. Its key contribution is the separation of peripheral CB2-linked anti-inflammatory effects from central CB1-associated modulation of trigeminal, pain, and serotonergic circuits.
Canagliflozin (hemihydrate): Reliable Cell Assays
2026-08-31
A scenario-based guide for using Canagliflozin (hemihydrate), SKU C6434, in glucose metabolism research and viability workflows. It connects formulation control, assay interpretation, and vendor documentation with evidence from a 2025 drug-sensitized yeast study.
Ionomycin Free Acid: Calcium Ionophore Guide
2026-08-31
Ionomycin free acid is a selective calcium ionophore that increases intracellular Ca2+ by transporting calcium across lipid membranes. This guide connects its experimentally documented ionophore activity with calcium-dependent assay design and the FAK–FAISL biology reported in triple-negative breast cancer research.
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-30
Track mRNA uptake with Cy5 while measuring functional protein production through Firefly Luciferase in the same experiment. This dual-readout format helps separate delivery, intracellular trafficking, and translation performance during transfection, formulation, and imaging studies.
Dimetridazole Workflows for Quorum Sensing Studies
2026-08-29
Dimetridazole supports more than growth-inhibition testing: it can help separate direct antimicrobial effects from quorum sensing, biofilm, and combination-therapy phenotypes. This practical workflow also shows how to control solvent effects, interpret redox measurements, and avoid confusing aqueous degradation with detoxification.
PRINT for Safe-Harbor Transgene Insertion
2026-08-29
The reference study introduces PRINT, an RNA-only genome-engineering strategy that repurposes avian R2 retroelement proteins for target-primed reverse transcription of transgenes into a multicopy human safe-harbor locus. Its reported efficiency in a cultured human primary cell line, together with the absence of extragenomic donor DNA, makes PRINT a mechanistically distinct alternative to DNA-break repair and viral delivery, although broader validation remains necessary.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page